• Home
  • Articles
  • COVID-19
  • News
    • Biotech News – Featured
    • Biotech News
    • BioGadgets
  • Interviews
    • Interviews – Academia
    • Interviews – Industry
  • Issues
  • Subscribe
  • Board
  • Advertise
Facebook Twitter Instagram
Trending
  • Highlights of India’s first Biotech startup Expo
  • NTU Singapore scientists develop a ‘fabric’ that turns body movement into electricity
  • Researchers who jumped into the field from distant disciplines published lower impact work, study finds
  • Amrita Vishwa Vidyapeetham gets CDSCO nod for clinical trials of first-of-its-kind synthetic jaw-bone graft
  • AstraZeneca Covid-19 vaccines which uses a chimpanzee adenovirus inked to monkeypox outbreak
  • Concerns Mount Over COVID-19 ‘Rebounds’ After Treatment With Pfizer’s Paxlovid
  • Moderna and Pfizer: Lawsuits and Charitable Giving
  • European Commission Approves Two GM Crops for Food and Feed
Biotech Express Magazine
  • Home
  • Articles
  • COVID-19
  • News
    • Biotech News – Featured
    • Biotech News
    • BioGadgets
  • Interviews
    1. Interviews – Academia
    2. Interviews – Industry
    Featured
    January 16, 20211

    Interview – Prof Rajeev K Varshney “The Youngest Indian Scientist (47)” who achieved an h-index of 100 recently

    Recent
    March 30, 2022

    Interview- Bioenergy: India’s Ministry of New and Renewable Energy started almost four decades ago…but did not catch up…, Professor Ashok Pandey

    January 24, 2022

    Interview: Prof Kailash Chander Bansal, Secretary, National Academy of Agricultural Sciences (NAAS), India

    January 23, 2022

    Interview – Dr Heera Lal: How an IAS officer using Biotech approaches to transform Indian villages into “Organic Villages”

  • Issues
  • Subscribe
  • Board
  • Advertise
Biotech Express Magazine
You are at:Home»Articles»New developments led by Prof Gajendra Raghava, IIIT-D in Computational biology

New developments led by Prof Gajendra Raghava, IIIT-D in Computational biology

0
By Biotech Express on December 18, 2021 Articles, Articles- Guestorials, BioResearch - Academic

Healthcare is an essential component in all human beings’ lives as each individual wishes to have a happy, healthy, and wealthy lifespan. A team led by Prof. Gajendra P. S. Raghava has developed a collation of computational tools that could be beneficial for biologists and non-biologists.

The recent review published in Wiley Interdisciplinary Reviews: Data Mining and Knowledge Discovery throw light on how computational resources play a vital role in healthcare. The Healthcare sector became more digitalized and advanced due to the evolving informatics-based fields like medical informatics, bioinformatics, cheminformatics, pharmacoinformatics, immunoinformatics, and clinical informatics. These domains generate a huge amount of biological and clinical data, such as electronic health records, biomedical images, and genomics. Globally, several researchers are developing various tools, software, and methods that can compile, store, annotate and analyze generated data and make it approachable.

“In the present scenario, there is a limited number of open-source software than commercial ones available for scientific and academic purposes. Our group is adherent of public domain software and thus initiated a web-portal Computational Resource for Drug Discovery (CRDD), an important insilico module under Open Source Drug Discovery (OSDD). The ideology behind this is to promote the open-source/ freeware software”, said Gajendra P. S. Raghava, Professor, and Head of Department of Computational Biology at Indraprastha Institute of Information Technology, New Delhi.

The advanced review entitled “Computational Resources in Healthcare” focused on summarizing various freeware and open-source computational tools widely implemented in different healthcare sectors. This study revolves around some major areas of healthcare like drug discovery, vaccine design and development, biomarker discovery, and Internet of Things (IoT) in healthcare.

“Drugs play an important role in treating any disease,” says Neelam Sharma from IIIT Delhi and one of the first co-authors of the paper. The drug development process is a time-consuming and costly affair, and thus a number of resources have been developed to facilitate it. In this study, the authors have summarized major resources commonly used for drug discovery.

“To fight any disease, one should have strong immunity, and vaccines play an important role in boosting it,” says Dr. Naorem Leimarembi Devi from IIIT Delhi and one of the first co-authors of the paper. The use of vaccines has efficaciously controlled contagious diseases like polio and smallpox. The conventional approach for vaccine development is a tedious process; thus, computational tools and databases make it easier to overcome the shortcomings and enhance the possibility of discovering potential vaccine candidates.

Several tools and databases are available for the identification of disease biomarkers which aids in disease diagnosis. Besides this, IoTs is an emerging field that has completely transformed the healthcare industry by bringing patients, doctors, and hospitals together. “IoT-based healthcare systems include mobile apps (AarogyaSetu), wearable devices (Fitbit) and telemedicine (eSanjeevaniOPD) has revolutionized the healthcare facilities and management,” says Satakshi Gupta from IIIT Delhi, one of the authors of the paper.

The researchers have further compiled all the computational resources related to healthcare in a single health portal named “PHI: Portal for Health Informatics,” accessible at https://webs.iiitd.edu.in/. The overall aim of this web portal is to help scientific and non-scientific communities working in the healthcare sector to have a glimpse of a wide range of open and freely available resources.

About Prof. Gajendra P.S. Raghava

Prof. Raghava is a Professor & Head at Department of Computational Biology, Indraprastha Institute of Information Technology (IIIT-Delhi), India. Before joining IIIT-Delhi in 2017, he was working as Chief Scientist at Bioinformatics Centre, CSIR-Institute of Microbial Technology (IMTECH), Chandigarh, India. He did M.Tech from Indian Institute of Technology (I.I.T.), New Delhi in 1986 and Ph.D. in Bioinformatics (1996) from IMTECH, Chandigarh. He worked as Postdoctoral fellow at Oxford university, Oxford and European Bioinformatics Institute, Cambridge UK (1996-98). Worked as Bioinformatics specialist at UAMS, USA (2002-3 & 2006) where he establish bioinformatics infrastructure.

Prof. Raghava has published more than 250 research papers in reputed journals with average impact factor around 4.0 Most of papers are highly cited, total citations nearly 20,000 with h-index 73 and g-index 195 as per google scholar.

Prof. Raghava is a strong supporter of open source software and open access, all resources developed at his group are free for scientific use. His group developed more than 250 web servers and 40 databases in the field of computer-aided drug/vaccine design (probably highest number of services developed/maintained from a single group in the world). These services are heavily used by scientific community, nearly 150,000 hits per day.

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
Biotech Express
  • Website
  • Facebook
  • Twitter
  • LinkedIn

ISSN: 2454-6968 | Biotech Express Magazine publishes articles in the field of biotechnology and allied sciences in a way that have never been presented earlier. It publishes Editorials, Guest Articles, Reports, Interviews, Current News of Govt. Academics and Business, Research Highlights and Notifications of Events, Jobs, Research Proposals in the field of Biotechnology, Biological Sciences, Life Sciences, Microbiology, Biochemistry, Neurosciences, Genetics, Medical Sciences, BioPharma etc.

Related Posts

NTU Singapore scientists develop a ‘fabric’ that turns body movement into electricity

No Vaccine Mandates after supreme court order, next compensation to AEFI survivors from COVID Vaccine makers possible?

Letter: Public Health Bill to be presented in the Monsoon session 2022 is Illegal, Unconstitutional and Arbitrary: Dr Maya Valecha

Leave A Reply Cancel Reply

Current Issue – May 2022

                   VIEW SUBSCRIPTION PLANS

JOBS/NOTIFICATIONS

   

         CLICK HERE FOR RECENT NOTICES

Recent Posts
  • Highlights of India’s first Biotech startup Expo June 13, 2022
  • NTU Singapore scientists develop a ‘fabric’ that turns body movement into electricity June 6, 2022
  • Researchers who jumped into the field from distant disciplines published lower impact work, study finds May 30, 2022
  • Amrita Vishwa Vidyapeetham gets CDSCO nod for clinical trials of first-of-its-kind synthetic jaw-bone graft May 26, 2022
  • AstraZeneca Covid-19 vaccines which uses a chimpanzee adenovirus inked to monkeypox outbreak May 25, 2022
  • Concerns Mount Over COVID-19 ‘Rebounds’ After Treatment With Pfizer’s Paxlovid May 25, 2022
  • Moderna and Pfizer: Lawsuits and Charitable Giving May 25, 2022
  • European Commission Approves Two GM Crops for Food and Feed May 25, 2022
  • Ayush Ministry, DBT sign MoU for cooperation on evidence-based biotech interventions in Ayush sector May 24, 2022
  • CCI, India merger approved absorption of Covidshield Technologies into Biocon Biologics May 20, 2022
  • No Vaccine Mandates after supreme court order, next compensation to AEFI survivors from COVID Vaccine makers possible? May 19, 2022
  • Industry lobbying on WHO overshadowing public health policy, researchers suggest May 18, 2022
  • Letter: Public Health Bill to be presented in the Monsoon session 2022 is Illegal, Unconstitutional and Arbitrary: Dr Maya Valecha May 15, 2022
  • Paid publishing in science has killed peer review system, says CSIR’s ex-chief Shekhar Mande May 15, 2022
  • Bill Gates tests positive for COVID-19 even after many booster doses, mocked on twitter May 10, 2022
  • Another Ivermectin COVID-19 paper retracted May 8, 2022
  • COVID-19 spike protein paper retracted May 7, 2022
  • Killer Music? Can sound make a clot in a boy who died while dancing or it is related to COVID vaccination May 7, 2022
  • Clotting Risks Cause FDA to Restrict Use of J&J COVID Vaccine May 6, 2022
  • Department of Pharmaceuticals releases “Common Guidelines on Pharmaceutical Innovation and Entrepreneurship” for academic institutions May 6, 2022
  • No medical care for 45% of recorded deaths in 2020, highest ever in India: New data May 6, 2022
  • Indian opposition seeks higher compensation for COVID deaths after damning WHO report May 6, 2022
  • Redcliffe Lifetech raises $61 million in Series B funding May 6, 2022
  • Engineers Create an Enzyme That Breaks Down Plastic Waste in Hours, Not Decades May 5, 2022
  • Eris Lifesciences acquires 100% stake in Oaknet Healthcare for Rs 650 cr May 5, 2022
  • The Union Government has Lied to the Supreme Court in COVID Vaccines Case? May 5, 2022
  • COVID-19- vitamin D paper from India retracted by Springer Nature journal May 4, 2022
  • IISc develops 3D printed gloves for rehabilitating stroke patients May 4, 2022
  • A new wearable technology — for plants May 4, 2022
  • Sanofi India names Rodolfo Hrosz managing director effective June 1 May 4, 2022
Archives
Categories
  • Articles
  • Articles- Editorials
  • Articles- Guestorials
  • BioControversial
  • BioEvents
  • BioGadgets
  • BioPolicies
  • BioResearch – Academic
  • Biotech News
  • Biotech News – Featured
  • Contents
  • Interviews
  • Interviews – Academia
  • Interviews – Industry
  • SARS- CoV2 & COVID-19 Updates
  • startups
About Us

Biotech Express Magazine publishes articles in the field of biotechnology and allied sciences in a way that have never been presented earlier. It publishes Editorials, Guest Articles, Reports,  Interviews, Current News of Govt. Academics and Business, Research Highlights and Notifications of Events, Jobs, Research Proposals in the field of Biotechnology and allied sciences like Biological Sciences, Life Sciences, Microbiology, Biochemistry, Neurology, Genetics, Medical Sciences, BioPharma etc.

Call us: _91-9311986177

Email – biotechexpressindia@gmail.com

About Us

About Biotech Express

Advisory and Editorial Board

Contact Us

Policy and Guidelines

Submission policies

Peer review policy    

Copyright policy

 

Follow Us
  • Facebook
  • Twitter
We use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies. Copyright © 2013-2020 Biotech Express except certain content provided by third parties.

Type above and press Enter to search. Press Esc to cancel.